Breaking News

USP Offers Support for COVID-19 Antiviral/Vax Developers

Aims to help developers ensure quality of their materials as they scale up manufacturing to bring products into clinical development.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The U.S. Pharmacopeia (USP) is providing free technical assistance to drug and vaccine developers to support the public health response to the COVID-19 pandemic. USP scientific teams will be available to help developers ensure the quality of their materials as they scale up manufacturing to bring products into clinical development. USP is extending the support to manufacturers of treatments for secondary implications of the outbreak such as bacterial infections, to help facilitate a greater...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters